Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-47.80	54.69	104.78
Graham Fair Price	27.18	40.74	32.04
PEG	72.80	0.49	-0.28
Price/Book	-7.52	5.52	5.97
Price/Cash Flow	77.62	-75.69	42.61
Prices/Earnings	-33.15	24.56	36.74
Price/Sales	-13.82	14.27	16.56
Price/FCF	77.62	-75.69	42.61
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.01	0.60	0.62
Operating Margin	50.45	0.22	0.15
ROA	45.07	0.02	0.01
ROE	0.04	0.06	38.34
ROIC	0.02	0.03	53.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.10	-17.49
Dividends QOQ	2.75	-1.00	-63.64
EBIT QOQ	1.51	0.75	-50.51
EPS QOQ	1.29	0.50	-61.31
FCF QOQ	1.44	-1.56	8.86
Revenue QOQ	0.15	0.16	9.15
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	279.45	221.37	-20.78
Days Sales Outstanding (DSO)	70.93	92.80	30.85
Inventory Turnover	0.32	0.41	26.24
Debt/Capitalization	0.57	0.57	-0.09
Quick Ratio	0.68	0.75	11.52
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.52	36.24	8.13
Cash	10.78	9.08	-15.73
Capex	-1.01	-0.45	55.22
Free Cash Flow	4.69	-2.64	-43.70
Revenue	12.07	14.01	16.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.27	1.31	2.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.59	9.55	-42.47
Naive Interpretation	Member

06 - Financial Health · Weak

Rating